Korean J Urol.  2011 Feb;52(2):119-123.

A Comparative Study of Clinical Symptoms and Treatment Outcomes of Acute Bacterial Prostatitis According to Urine Culture

• Lee SJ
• Lee DH
• Park YY
• Shim BS

Abstract

PURPOSE
Because acute bacterial prostatitis (ABP) is an urgent condition of the prostate but prostatic massage is contraindicated at the onset of ABP, clinical symptoms and urine tests are used for diagnosis. In this study, we compared the clinical symptoms and treatment outcomes of patients with negative urine culture results, to whom only empirical antibiotics were administered, with those of patients with positive urine culture results.
MATERIALS AND METHODS
Patients were divided into two groups according to the results of urine culture. Then, the clinical symptoms and course of each group were analyzed. In addition, age, symptoms, antibiotics, mean inpatient and outpatient length of treatment, and the treatment outcome of each group were also analyzed.
RESULTS
Of the total 144 patients, the positive urine culture group consisted of 51 patients (35.4%) and the most frequent bacterial strain causing ABP was reported to be Escherichia coli. Fever and storage symptoms were significantly more common in the positive urine culture group than in the negative urine culture group (p=0.031 and 0.047, respectively). Only inpatient treatment was significant longer in the positive urine culture group than in the negative urine culture group (p<0.05). The mean length of treatment of inpatients was 4.8+/-2.6 days and 6.2+/-2.9 days in the two groups, respectively. No sequelae such as prostatic abscess or chronic prostatitis were found in either group.
CONCLUSIONS
In the treatment of ABP, the use of empirical antibiotics can be expected to have sufficient effects regardless of bacterial culture. However, it is hard to determine the causative bacteria of ABP by urine culture results only.

Keyword

Culture; Prostatitis; Signs and symptoms

MeSH Terms

Abscess
Anti-Bacterial Agents
Bacteria
Escherichia coli
Fever
Humans
Inpatients
Massage
Outpatients
Prostate
Prostatitis
Sprains and Strains
Treatment Outcome
Anti-Bacterial Agents

Reference

1. Neal DE Jr. Nickel JC, editor. Acute bacterial prostatitis. Textbook of prostatitis. 1999. 1st ed. Oxford: Isis Medical Media;115–121.

2. Ha US, Kim ME, Kim CS, Shim BS, Han CH, Lee SD, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008. 31:Suppl 1. S96–S101.

3. Lee JY, Kim SJ, Ahn HS. The value of serum prostate-specific antigen in the diagnosis and follow-up of acute prostatitis. Korean J Urol. 2001. 42:800–803.

4. Crawford ED, Haynes AL Jr, Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol. 1982. 127:449–451.

5. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, et al. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Eur Urol. 2001. 40:576–588.

6. Cho IR, Lee KC, Lee SE, Jeon JS, Park SS, Sung LH, et al. Clinical outcome of acute bacterial prostatitis, a multicenter study. Korean J Urol. 2005. 46:1034–1039.

7. Hua VN, Schaeffer AJ. Acute and chronic prostatitis. Med Clin North Am. 2004. 88:483–494.

8. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999. 282:236–237.

9. Vahlensieck W Jr, Hofstetter AG. Weider W, Madsen PO, Schiefer HG, editors. Acute prostatitis and prostatic abscess. Prostatitis. 1994. 1st ed. Berlin: Springer-Verlag;133–148.

10. Schaeffer AJ. Diagnosis and treatment of prostatic infections. Urology. 1990. 36:5 Suppl. 13–17.

11. Naber KG, Weidner W. Armstrong D, Cohen J, editors. Prostatitis, epididymitis and orchitis. Infectious disease. 1999. 3rd ed. London: Mosby;1–58.

12. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol. 2000. 164:76–80.

13. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000. 85:682–685.

14. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol. 1997. 157:2199–2200.

15. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998. 52:552–558.

16. Shigehara K, Miyagi T, Nakashima T, Shimamura M. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother. 2008. 14:40–43.

17. Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J Urol. 2008. 179:952–955.

18. Kim ME, Ha US, Cho YH. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006. Int J Antimicrob Agents. 2008. 31:Suppl 1. S15–S18.

19. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999. 29:745–758.

20. Naber KG, Bishop MC, Bjerklund-johansen TE, Botto H, Cek M, Grabe M, et al. EAU guideline office. The management of urinary and male genital tract infections. European Association of Urology Guidelines. 2006. Arnhem: Drukkerij Gelderland;1–126.